GO
Loading...

Amgen Inc

More

  • July 29- Amgen Inc on Tuesday said it would cut up to 15 percent of its work force and close plants in a series of moves aimed at reallocating resources as it prepares to introduce new medicines it hopes will drive future growth.

  • July 29- Amgen Inc on Tuesday said it would cut up to 15 percent of its global work force and close plants as part of a series of moves aimed at reallocating resources as it prepares for the eventual launch of medicines it hopes will drive future growth.

  • July 29- Amgen Inc on Tuesday posted higher-than-expected second-quarter profit in a rebound from a disappointing first quarter, helped by strong sales of its rheumatoid arthritis drug Enbrel, and it significantly raised its full-year earnings forecast.

  • Biotech drugmaker Amgen laying off at least 2,400 Tuesday, 29 Jul 2014 | 4:04 PM ET

    Biologic drugmaker Amgen said Tuesday that it will lay off 12 to 15 percent of its worldwide workforce and close four sites, even as it reported stellar second-quarter results that trounced Wall Street expectations. Amgen also raised its forecasts for its 2014 profit and revenue, driving up its shares.

  • Final Glance: Biotechnology companies Monday, 28 Jul 2014 | 6:04 PM ET

    Amgen Inc. fell$. 19 or. 2 percent, to $122.65. Biogen Idec rose$. 94 or. 3 percent, to $336.39. Celgene Corp. rose$. 48 or. 6 percent, to $87.64.

  • Business events scheduled for Tuesday Monday, 28 Jul 2014 | 2:10 PM ET

    WASHINGTON— Standard& Poor's releases S&P/Case-Shiller index of home prices for May, 9 a.m.. WASHINGTON— The Conference Board releases the Consumer Confidence Index for July, 10 a.m.. WASHINGTON— House Energy and Commerce subcommittee hearing on EPA's proposed clean power plan and grid reliability challenges.

  • Midday Glance: Biotechnology companies Monday, 28 Jul 2014 | 1:31 PM ET

    Amgen Inc. fell$. 84 or. 7 percent, to $122.00. Biogen Idec fell$. 40 or. 1 percent, to $335.05. Celgene Corp. fell$. 19 or. 2 percent, to $86.97.

  • Early Glance: Biotechnology companies Monday, 28 Jul 2014 | 10:33 AM ET

    Amgen Inc. fell$. 67 or. 5 percent, to $122.17. Biogen Idec fell$. 97 or. 3 percent, to $334.48. Celgene Corp. fell$. 48 or. 6 percent, to $86.68.

  • Final Glance: Biotechnology companies Thursday, 24 Jul 2014 | 6:22 PM ET

    Amgen Inc. rose$. 25 or. 2 percent, to $122.26. Biogen Idec fell$. 81 or. 2 percent, to $336.79. Celgene Corp. fell $2.93 or 3.3 percent, to $86.19.

  • FDA reviewing what could be first biosimilar drug Thursday, 24 Jul 2014 | 3:41 PM ET

    Nearly five years after Congress passed a law enabling future approval of biosimilars, for the first time the FDA has accepted an application to sell a similar, but not identical, version of a biologic drug.

  • Midday Glance: Biotechnology companies Thursday, 24 Jul 2014 | 1:23 PM ET

    Biogen Idec fell$. 94 or. 3 percent, to $336.66. Celgene Corp. fell $3.22 or 3.6 percent, to $85.90. Gilead Sciences Inc. rose$. 04 or percent, to $90.38.

  • Early Glance: Biotechnology companies Thursday, 24 Jul 2014 | 11:37 AM ET

    Amgen Inc. fell$. 51 or. 4 percent, to $121.50. Biogen Idec rose$. 29 or. 1 percent, to $337.89. Celgene Corp. fell $3.63 or 4.1 percent, to $85.49.

  • Final Glance: Biotechnology companies Tuesday, 22 Jul 2014 | 6:02 PM ET

    Amgen Inc. rose $2.08 or 1.7 percent, to $121.11. Biogen Idec rose $1.17 or. 4 percent, to $303.67. Celgene Corp. rose $1.35 or 1.6 percent, to $86.66.

  • Midday Glance: Biotechnology companies Tuesday, 22 Jul 2014 | 1:57 PM ET

    Amgen Inc. rose $1.68 or 1.4 percent, to $120.71. Biogen Idec rose $2.64 or. 9 percent, to $305.14. Celgene Corp. rose $1.30 or 1.5 percent, to $86.61.

  • Early Glance: Biotechnology companies Tuesday, 22 Jul 2014 | 11:16 AM ET

    Amgen Inc. rose $1.30 or 1.1 percent, to $120.33. Biogen Idec rose $5.25 or 1.7 percent, to $307.75. Celgene Corp. rose $1.69 or 2.0 percent, to $87.00.

  • Midday Glance: Biotechnology companies Wednesday, 16 Jul 2014 | 2:54 PM ET

    Amgen Inc. rose$. 05 or percent, to $116.91. Biogen Idec fell $6.64 or 2.1 percent, to $305.36. Celgene Corp. fell$. 70 or. 8 percent, to $86.08.

  • Early Glance: Biotechnology companies Wednesday, 16 Jul 2014 | 11:11 AM ET

    Amgen Inc. rose$. 29 or. 3 percent, to $117.16. Biogen Idec fell $4.28 or 1.4 percent, to $307.72. Celgene Corp. rose$. 21 or. 2 percent, to $86.99.

  • Ernst & Young to pay $4 million in SEC settlement Monday, 14 Jul 2014 | 3:40 PM ET
    Ernst and Young signage in New York City.

    Accounting giant Ernst & Young will pay $4 million to settle civil charges that it violated auditor independence rules, U.S. regulators said.

  • In 2012, Ernst& Young voluntarily decided to cease performing lobbying work for SEC registrant audit clients. " "Auditor independence is critical to the integrity of the financial reporting process," said Scott Friestad, an associate director in the SEC's enforcement division.

  • Early movers: APP, MS, LULU, BIND, ABBV & more Thursday, 3 Jul 2014 | 7:52 AM ET
    Traders on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.